Ranitidine
Composition
Ranitidine tablets contain the active ingredient ranitidine hydrochloride, along with excipients like microcrystalline cellulose, magnesium stearate, and colloidal silicon dioxide. These ingredients help stabilize the drug, aid in its absorption, and ensure tablet integrity.
Indications
Ranitidine is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and conditions requiring reduction of stomach acid production.
Side effects
Common side effects include headache, dizziness, and constipation; rare but serious side effects include liver dysfunction and severe allergic reactions.
Precautions
Use with caution in patients with renal or hepatic impairment, and monitor for potential signs of gastrointestinal bleeding or severe allergic reactions.
Contraindications
Contraindicated in patients with known hypersensitivity to ranitidine or any of its components.
Dosage and administration
Typically administered at 150 mg twice daily or 300 mg once daily at bedtime, adjusted based on the condition and patient response. Always follow the prescribing physician's instructions.
Countries
Worldwide
Available Forms
Tablets, injectable solutions
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai